Now expects 2024 turnover growth increase of 7% to 9% previously 5% to 7%; Core operating profit growth of 11% to 13% previously 9% to 11%.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GSK: